Showing results (11-20 of 770) with videos related to
Sort By:
Pageof 77
Current Opinion in Oncology|August 14, 2018
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomasMirco Friedrich, Lukas Bunse, Wolfgang Wick, et al.Cancer Research|October 24, 2012
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletionMichael Platten, Wolfgang Wick, Benoît J Van den EyndeInternational Journal of Molecular Sciences|December 10, 2021
Genetically Modified Cellular Therapies for Malignant GliomasMichael Kilian, Theresa Bunse, Wolfgang Wick, et al.Current Neurology and Neuroscience Reports|March 8, 2014
Microenvironmental clues for glioma immunotherapyMichael Platten, Katharina Ochs, Dieter Lemke, et al.Current Treatment Options in Neurology|March 30, 2018
Vaccine Strategies in GliomasMichael Platten, Lukas Bunse, Dennis Riehl, et al.Frontiers in Immunology|January 29, 2015
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream EffectorsMichael Platten, Nikolaus von Knebel Doeberitz, Iris Oezen, et al.Neuro-Oncology|June 4, 2011
Pathway inhibition: emerging molecular targets for treating glioblastomaWolfgang Wick, Michael Weller, Markus Weiler, et al.BMC Cancer|April 13, 2011
Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastomaClemens Seidel, Nils Dörner, Matthias Osswald, et al.Neuro-Oncology|October 14, 2015
Current status and future directions of anti-angiogenic therapy for gliomasWolfgang Wick, Michael Platten, Antje Wick, et al.Amino Acids|April 20, 2017
Suppression of Th1 differentiation by tryptophan supplementation in vivoTobias V Lanz, Simon Becker, Soumya R Mohapatra, et al.Pageof 77